Yunzhi Ling

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Topics

Immune Response

Signaling Pathway

Mycobacterium Tuberculosis

Top Venues

Oxidative medicine and cellular longevity

Computational and mathematical methods in medicine

Biomaterials science

This page only lists publications with an associated author ORCID identifier.

Publications

Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Huijuan Li, Yan Li, Chunxiang Luo, Xueyan Liang, Zixuan Liu, Yu Liu, Yunzhi Ling
New Approach for Targeted Treatment of Mild COVID-19 by Honeysuckle through Network Pharmacology Analysis. Computational and mathematical methods in medicine 2022 (2022)
Min Yang, Zhanxue Xu, Hailan Yan, Hsiang-I Tsai, Dandan Su, Fuxia Yan, Qiumei Lu, Jianhua Feng, Weiwei Zeng, Lifang Xi, Hualian Zha, Yunzhi Ling, Chao He, Yingyi Wu, Xiaowei Xu, Gang Zheng, Gan Liu, Hongbo Chen, Fang Cheng
PD-L1 cellular nanovesicles carrying rapamycin inhibit alloimmune responses in transplantation. Biomaterials science 9 (4) (2021)